ImCheck Therapeutics Competitors and Similar CompaniesClear all

ImCheck Therapeutics's competitors and similar companies include MedDay, Rubius Therapeutics and Adicet Bio.

	ImCheck Therapeutics ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .	MedDay MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.	Rubius Therapeutics Rubius is developing a new class of drugs, Red-Cell Therapeutics™.	Adicet Bio Adicet Bio is a biotechnology company that develops therapies for cancer diseases.
Founding Date	Founding Date 2015	Founding Date 2011	Founding Date 2013	Founding Date 2016
Type	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy
Locations	Locations Marseille, FR HQ	Locations Clichy, FR HQ Paris, FR Boston, US	Locations Cambridge, US HQ Smithfield, US	Locations Redwood City, US HQ Boston, US
Employees	Employees 57	Employees 3710% decrease	Employees 17423% increase	Employees 1438% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 7.5 m	Valuation ($) 116.2 m
Financial
Net income	Net income N/A	Net income N/A	Net income ($179.7m) (FY, 2022)	Net income ($116.8m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 53.2m (over 6 years ago)	Latest funding round $ 38.5m (over 10 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 76.1m	Total funding raised $ 48.9m	Total funding raised $ 245m	Total funding raised $ 145.6m